// App-Quantinova.ai

PB0377 : Heparin and heparin proteoglycan-mimetics activate platelets via PEAR1 and PI3Kbeta

Researchers

Presenter

  • C. Kardeby

Principal Investigators

  • A. Evans

  • J. Campos

  • C. Smith

  • A. Slater

  • E. Martin

  • S. Severin

  • A. Brill

  • Y. Sun

  • S. Watson

Medical Centers

  • University of Birmingham, Birmingham, United Kingdom

  • Institute of metabolic and cardiovascular diseases, Toulouse cedex 04, Midi-Pyrenees, France

  • Uppsala University, Uppsala, Uppsala Lan, Sweden

  • University of Birmingham, Birmingham, UK, Birmingham, England, United Kingdom

Locations

  • United Kingdom

  • France

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Human albumin

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A